[Pharmacological testing of the system of biotransformation of xenobiotics]. 1988

V G Kukes, and I L Blinkov, and A K Starodubtsev, and E A Fedorov, and G A Beliakova

UI MeSH Term Description Entries
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000107 Acetylation Formation of an acetyl derivative. (Stedman, 25th ed) Acetylations
D000983 Antipyrine An analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (From Martindale, The Extra Pharmacopoeia, 30th ed, p29) Phenazone,Anodynin,Pyramidone
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.

Related Publications

V G Kukes, and I L Blinkov, and A K Starodubtsev, and E A Fedorov, and G A Beliakova
January 2014, Nucleic acids research,
V G Kukes, and I L Blinkov, and A K Starodubtsev, and E A Fedorov, and G A Beliakova
January 1980, Pharmacology & therapeutics,
V G Kukes, and I L Blinkov, and A K Starodubtsev, and E A Fedorov, and G A Beliakova
January 1980, Drug metabolism reviews,
V G Kukes, and I L Blinkov, and A K Starodubtsev, and E A Fedorov, and G A Beliakova
August 2020, Phytochemistry,
V G Kukes, and I L Blinkov, and A K Starodubtsev, and E A Fedorov, and G A Beliakova
April 2001, Fundamental & clinical pharmacology,
V G Kukes, and I L Blinkov, and A K Starodubtsev, and E A Fedorov, and G A Beliakova
December 2000, Current drug metabolism,
V G Kukes, and I L Blinkov, and A K Starodubtsev, and E A Fedorov, and G A Beliakova
December 1979, Environmental health perspectives,
V G Kukes, and I L Blinkov, and A K Starodubtsev, and E A Fedorov, and G A Beliakova
January 2021, Current drug metabolism,
V G Kukes, and I L Blinkov, and A K Starodubtsev, and E A Fedorov, and G A Beliakova
June 1988, Gigiena i sanitariia,
V G Kukes, and I L Blinkov, and A K Starodubtsev, and E A Fedorov, and G A Beliakova
January 2016, Parazitologiia,
Copied contents to your clipboard!